These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25572400)

  • 1. Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.
    Rouget R; Sharma G; LeBlanc AC
    J Biol Chem; 2015 Feb; 290(9):5759-71. PubMed ID: 25572400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of prion protein at serine 43 induces prion protein conformational change.
    Giannopoulos PN; Robertson C; Jodoin J; Paudel H; Booth SA; LeBlanc AC
    J Neurosci; 2009 Jul; 29(27):8743-51. PubMed ID: 19587281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of prion protein assembly into amyloid.
    Stöhr J; Weinmann N; Wille H; Kaimann T; Nagel-Steger L; Birkmann E; Panza G; Prusiner SB; Eigen M; Riesner D
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2409-14. PubMed ID: 18268326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
    Vanik DL; Surewicz WK
    J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion.
    Hafner-Bratkovic I; Bester R; Pristovsek P; Gaedtke L; Veranic P; Gaspersic J; Mancek-Keber M; Avbelj M; Polymenidou M; Julius C; Aguzzi A; Vorberg I; Jerala R
    J Biol Chem; 2011 Apr; 286(14):12149-56. PubMed ID: 21324909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
    Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
    Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
    Ladner-Keay CL; Griffith BJ; Wishart DS
    PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions.
    Nyström S; Hammarström P
    Sci Rep; 2015 May; 5():10101. PubMed ID: 25960067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro.
    Jones EM; Surewicz K; Surewicz WK
    J Biol Chem; 2006 Mar; 281(12):8190-6. PubMed ID: 16443601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid nucleation and hierarchical assembly of Ure2p fibrils. Role of asparagine/glutamine repeat and nonrepeat regions of the prion domains.
    Jiang Y; Li H; Zhu L; Zhou JM; Perrett S
    J Biol Chem; 2004 Jan; 279(5):3361-9. PubMed ID: 14610069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.
    Moore RA; Herzog C; Errett J; Kocisko DA; Arnold KM; Hayes SF; Priola SA
    Protein Sci; 2006 Mar; 15(3):609-19. PubMed ID: 16452616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y145Stop is sufficient to induce de novo generation prions using protein misfolding cyclic amplification.
    Abdallah A; Wang P; Richt JA; Sreevatsan S
    Prion; 2012; 6(1):81-8. PubMed ID: 22453182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
    Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
    Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The native state of prion protein (PrP) directly inhibits formation of PrP-amyloid fibrils in vitro.
    Honda RP; Kuwata K
    Sci Rep; 2017 Apr; 7(1):562. PubMed ID: 28373719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates.
    Almstedt K; Nyström S; Nilsson KP; Hammarström P
    Prion; 2009; 3(4):224-35. PubMed ID: 19923901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.